The California Stem Cell Report will bring you on-the-scene,
live, gavel-to-gavel coverage tomorrow of the meeting of the directors of the
Golden State’s $3 billion stem cell research program.
Directors are expected to approve $16.6 million for a “teabag” treatment for diabetes that is being developed by Viacycte, Inc., of San Diego. Also on the agenda is a move to ease revolving-door problems at the agency that may recur as some of its employees seek jobs
elsewhere.
The meeting begins at 10 a.m. PDT and will be audiocast on
the Internet for those who want to listen. To see the PowerPoint slides
being used during the meeting, you can also log on to a WebEx presentation. The agenda has instructions on how to take advantage of these opportunities.
Stem cell fanciers in Ohio will be able to actually take
part from a location at the Downtown Hilton at 401 N. High St. in Columbus. The
room number was not specified on the meeting agenda, so interested parties
should query the agency in advance at info@cirm.ca.gov.
Remote participation locations in California outside of Berkeley include two in Los
Angeles one each in La Jolla, Duarte and
Mountain View. Remote locations are provided when some directors are unable to attend meetings.
No comments:
Post a Comment